Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16

Benzinga Newsdesk www.benzinga.com Positive 70.0%

Neg 0% Neu 0% Pos 70%

Canaccord Genuity analyst Richard Close maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $14 to $16.